beta

CUR

Neuralstem Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Neuralstem Inc is a biotechnology company. It is engaged in the development and commercialization of treatments for central nervous system disease based on transplanting human neural stem cells and the use of small molecule drugs.

Market Cap: 29.7 Million

Primary Exchange: NASDAQ Capital Market

Website: http://www.neuralstem.com

Shares Outstanding: 15.1 Million

Float: 12.1 Million

Dividend: 0.0 (0.0%)

Beta: 1.579865

Sector: Healthcare

Industry: Biotechnology

Ethical Flags

Longest drawdown: 1423 trading days

From: 2014-04-09 To: 2019-10-30

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2017-01-09 13.0 1.0 13.0
Data provided by IEX Cloud